INTERNATIONAL FLAVORS & FRAGRANCES INC
IFFAPI behind this page
IFF Q3 2025 request
Playground key active
/api/financials?ticker=IFF&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 2,694 | 2,925 | -7.9% |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 830 | 843 | -1.5% |
| Health & Biosciences · Operating Segments | 577 | 568 | +1.6% |
| Scent · Operating Segments | 652 | 613 | +6.4% |
| Taste · Operating Segments | 635 | 623 | +1.9% |
Show Geography breakouts |
|||
| Asia | 617 | 694 | -11.1% |
| EMEA | 933 | 964 | -3.2% |
| Latin America | 365 | 381 | -4.2% |
| Net sales attributed to all foreign countries · Geographic Concentration Risk | 1,957 | 2,091 | -6.4% |
| North America | 779 | 886 | -12.1% |
| US · Geographic Concentration Risk | 737 | 834 | -11.6% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 2,694 | 2,925 | -7.9% |
| Cost of Revenue | 1,711 | 1,873 | -8.6% |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 642 | 668 | -3.9% |
| Health & Biosciences · Operating Segments | 315 | 305 | +3.3% |
| Scent · Operating Segments | 374 | 353 | +5.9% |
| Taste · Operating Segments | 379 | 369 | +2.7% |
| Gross Profit | 983 | 1,052 | -6.6% |
| Research & Development | 174 | 162 | +7.4% |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 13 | 17 | -23.5% |
| Health & Biosciences · Operating Segments | 57 | 44 | +29.5% |
| Scent · Operating Segments | 63 | 57 | +10.5% |
| Taste · Operating Segments | 41 | 38 | +7.9% |
| Selling, General & Administrative | 421 | 495 | -14.9% |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 104 | 99 | +5.1% |
| Health & Biosciences · Operating Segments | 87 | 96 | -9.4% |
| Scent · Operating Segments | 97 | 94 | +3.2% |
| Taste · Operating Segments | 103 | 103 | 0.0% |
| Operating Income | 226 | 249 | -9.2% |
| Interest Income | 4 | 3 | +33.3% |
| Other Non-Operating Income (Expense) | 14 | 28 | -50.0% |
| Income Before Taxes | 56 | 95 | -41.1% |
| Income Tax Expense (Benefit) | 15 | 36 | -58.3% |
| Net Income | 41 | 59 | -30.5% |
| Net Income | 40 | 58 | -31.0% |
| Comprehensive Income | -8 | 613 | -101.3% |
| EPS (Basic) | 0.16 | 0.23 | -30.4% |
| EPS (Diluted) | 0.16 | 0.23 | -30.4% |
| Wtd Avg Shares (Basic) | 256 | 256 | 0.0% |
| Wtd Avg Shares (Diluted) | 257 | 257 | 0.0% |
| Net Income Loss Attributable To Noncontrolling Interest | 1 | 1 | 0.0% |
| Interest Expense | 48 | 74 | -35.1% |
| Foreign Currency Transaction Gain Loss Before Tax | -21 | -31 | +32.3% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 621 | 567 | +9.5% |
| Inventory | 2,323 | 2,200 | +5.6% |
| Total Current Assets | 5,876 | — | — |
| Non-Current Assets | |||
| Property, Plant & Equipment | 3,868 | 3,772 | +2.5% |
| Operating Lease Right-of-Use Assets | 595 | — | — |
Show Disposal Group Classification breakouts |
|||
| Disposal Group Heldforsale Not Discontinued Operations · SCL Disposal Group | 7 | — | — |
| Goodwill | 8,264 | — | — |
Show Business Segments breakouts |
|||
| Health & Biosciences | 4,460 | — | — |
| Scent | 1,509 | — | — |
| Taste | 2,295 | — | — |
| Intangible Assets | 6,183 | — | — |
| Other Non-Current Assets | 982 | — | — |
| Total Assets | 25,768 | — | — |
| Current Liabilities | |||
| Accounts Payable | 1,284 | 1,211 | +6.0% |
| Commercial Paper | 370 | — | — |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 370 | — | — |
| Estimate Of Fair Value Fair Value Disclosure | 370 | — | — |
| Current Portion of Long-Term Debt | -1,308 | -468 | -179.5% |
| Total Current Liabilities | 4,069 | — | — |
| Debt Current | 1,308 | 468 | +179.5% |
| Non-Current Liabilities | |||
| Long-Term Debt | 4,741 | 8,631 | -45.1% |
| Deferred Tax Liabilities | 1,345 | — | — |
| Other Non-Current Liabilities | 611 | — | — |
| Stockholders' Equity | |||
| Common Stock | 35 | 35 | 0.0% |
| Retained Earnings | -3,345 | — | — |
| Accumulated Other Comprehensive Income | -1,463 | — | — |
| Total Stockholders' Equity | 14,241 | — | — |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -149 | -238 | +37.4% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -3 | -4 | +25.0% |
| Accumulated Other Comprehensive Income | -1,463 | -1,760 | +16.9% |
| Accumulated Translation Adjustment | -1,311 | -1,518 | +13.6% |
| Total Liabilities & Equity | 25,768 | — | — |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 725 | 772 | -6.1% |
| Stock-Based Compensation | 72 | 59 | +22.0% |
| Deferred Income Taxes | -213 | -143 | -49.0% |
| Change in Accounts Receivable | -195 | -276 | +29.3% |
| Change in Inventory | -129 | -3 | -4200.0% |
| Change in Accounts Payable | 28 | -34 | +182.4% |
| Net Cash from Operations | 532 | 681 | -21.9% |
| Investing Activities | |||
| Capital Expenditures | -406 | -303 | -34.0% |
| Net Cash from Investing | 2,426 | 607 | +299.7% |
| Financing Activities | |||
| Tax Withholding for Share Compensation | -23 | -15 | -53.3% |
| Debt Repayments (YTD) | — | — | — |
Show Debt Instrument breakouts |
|||
| 2026 Term Loan Facility · Loans Payable | 413 | 157 | +163.1% |
| Net Cash from Financing | -2,891 | -1,444 | -100.2% |
| Supplemental | |||
| Interest Paid | 175 | 216 | -19.0% |
| Unpaid Capital Expenditures | 92 | 74 | +24.3% |
| Other Cash Flow | |||
| Net Change in Cash | 150 | -166 | +190.4% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.